Literature DB >> 2478289

Cell cycle phase dependent emergence of thymidylate synthase studied by monoclonal antibody (M-TS-4).

S Shibui1, T Hoshino, K Iwasaki, K Nomura, M M Jastreboff.   

Abstract

A method of identifying thymidylate synthase (TS) at the cellular level was developed using anti-TS monoclonal antibody (M-TS-4), a monoclonal antibody created against purified TS from a HeLa cell line. In HeLa cells and four human glioma cell lines (U-251, U-87, 343-MGA, and SF-188), TS was identified primarily in the cytoplasm. Autoradiographic and flow cytometric studies showed that TS appeared mainly in the G1 phase and subsided early in the S phase; thus, the G1 phase can be divided into TS-positive and -negative fractions. Nuclear TS was not demonstrated unequivocally with M-TS-4, and the relationship between nuclear TS and DNA synthesis could not be determined. Although the percentage of TS-positive cells was larger than the S-phase fraction measured by autoradiography after a pulse of tritiated thymidine or by the immunoperoxidase method using BUdR, the ratios were within a similar range (1.2-1.4) in all cell lines studied. Therefore, the S-phase fraction can be estimated indirectly from the percentage of TS-positive cells measured by M-TS-4. Because the emergence of TS detected by our method is cell cycle dependent, M-TS-4 may be useful for biochemical studies of TS and for cytokinetic analysis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478289     DOI: 10.1111/j.1365-2184.1989.tb00211.x

Source DB:  PubMed          Journal:  Cell Tissue Kinet        ISSN: 0008-8730


  3 in total

1.  Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.

Authors:  J H van Dierendonck; J H Wijsman; R Keijzer; C J van de Velde; C J Cornelisse
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

2.  Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication.

Authors:  G Gribaudo; L Riera; D Lembo; M De Andrea; M Gariglio; T L Rudge; L F Johnson; S Landolfo
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 3.  The application of 5-bromodeoxyuridine in the management of CNS tumors.

Authors:  A Freese; D O'Rourke; K Judy; M J O'Connor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.